CTRI/2024/07/071627招募中Unknown
A Phase-IV multicentre follow-up study to assess the continued safety of Biological E’s 14-valent pneumococcal polysaccharide conjugate vaccine in subjects, who received 3-dose (3 plus 0) primary PCV vaccination as part of BECT051 and BECT061 studies. - Nil
试验速览
- 阶段
- Unknown
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All Subjects who participated and completed all study related visits and assessments, part of BECT051 and BECT061 studies.
- •2. Subjects’ parent(s)or LAR(s) who, in the opinion of the investigator, can and will comply, with the requirements of the protocol.
- •3. Subject’s parent(s)or LAR(s) willing to provide written or thumb printed informed consent prior to performing any study specific procedure or assessments.
排除标准
- •1. Subjects who dropped out from BECT051 or BECT061 studies.
- •2. Subjects who participated in another clinical study from the completion of the BECT051 and BECT061 studies until the commencement of current study.
- •3. Subject is a direct descendant (child or grand-child) of any person employed by the Sponsor, the Contract Research Organization (CRO) or the Study Site (including the PI and study site personnel).
研究者
相似试验
已完成
4 期
A multicenter phase IV clinical trial to examine the change of low-grade side effects after switch to Nilotinib from other tyrosine kinase inhibitors.CML chronic phaseJPRN-UMIN000008995Tokyo CML Conference55
招募中
1 期
Surgical resection combined with intraperitoneal chemotherapy (CT) is the best treatment for selected patients with Peritoneal Metastases from colon cancer. However, the real role of intraperitoneal CT as a necessary component of this treatment is unknown, despite its proven experimental basis. The main objective of this study is to clarify it, so one group of patients will be treated with surgery + intraperitoneal CT and the other with surgery alone.Surgical resection combined with intraperitoneal chemotherapy (CT) is the best treatment for selected patients with Peritoneal Metastases from colon cancer. However, the real role of intraperitoneal CT as a necessary component of this treatment is unknown, despite its proven experimental basis. The main objective of this study is to clarify it, so one group of patientes will be treated with surgery + intraperitoneal CT and the other with surgery alone.EUCTR2019-004679-37-ESHospital Universitario de Fuenlabrada216
进行中（未招募）
4 期
A clinical study to assess the safety of BEs Pneumococcal conjugate vaccine when administered in a three dose schedule.CTRI/2023/09/057894Biological ELimited
进行中（未招募）
1 期
A phase IV, open, multicentric study to evaluate the immune response to a hepatitis B challenge dose in healthy subjects, 72 to 78 months after they received a primary vaccination course of GSK Biologicals’ Engerix™-B (thiomersal-free 20 µg or preservative-free 10 µg) vaccine, in the primary study HBV-280. - HBV-314 BST: 280Hepatitis B vaccine challenge dose given to subjects, 17 to 21 years of age, to evaluate immune memory to Hepatitis B antigen, approximately 6 years after priming with Hepatitis B vaccine.EUCTR2007-000261-38-BEGlaxoSmithKline Biologicals250
招募中
1 期
Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after complete surgical debulking in patients with peritoneal metastases of colon cancer.peritoneal metastases of colorectal cancerCTIS2024-512726-28-00Hospital Universitario De Fuenlabrada216